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atSRp30, one of two SF2/ASF-like
proteins from Arabidopsis thaliana,
regulates splicing of specific plant genes
Sergiy Lopato,1 Maria Kalyna,1 Silke Dorner,1 Ryuji Kobayashi,2 Adrian R. Krainer,2
and Andrea Barta1,3
1Institut fu¨r Biochemie, Universita¨t Wien, Vienna Biocenter, A-1030 Vienna, Austria; 2Cold Spring Harbor Laboratory,
Cold Spring Harbor, New York 11724-2208 USA
SR proteins are nuclear phosphoproteins with a characteristic Ser/Arg-rich domain and one or two RNA
recognition motifs. They are highly conserved in animals and plants and play important roles in spliceosome
assembly and alternative splicing regulation. We have now isolated and partially sequenced a plant protein,
which crossreacts with antibodies to human SR proteins. The sequence of the corresponding cDNA and
genomic clones from Arabidopsis revealed a protein, atSRp30, with strong similarity to the human SR protein
SF2/ASF and to atSRp34/SR1, a previously identified SR protein, indicating that plants possess two
SF2/ASF-like proteins. atSRp30 expresses alternatively spliced mRNA isoforms that are expressed
differentially in various organs and during development. Overexpression of atSRp30 via a strong constitutive
promoter resulted in changes in alternative splicing of several endogenous plant genes, including atSRp30
itself. Interestingly, atSRp30 overexpression resulted in a pronounced down-regulation of endogenous mRNA
encoding full-length atSRp34/SR1 protein. Transgenic plants overexpressing atSRp30 showed morphological
and developmental changes affecting mostly developmental phase transitions. atSRp30- and atSRp34/
SR1-promoter–GUS constructs exhibited complementary expression patterns during early seedling
development and root formation, with overlapping expression in floral tissues. The results of the structural
and expression analyses of both genes suggest that atSRp34/SR1 acts as a general splicing factor, whereas
atSRp30 functions as a specific splicing modulator.
[Key Words: SR proteins; alternative splicing; pre-mRNA processing; plant development; overexpression;
phenotype]
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Alternative pre-mRNA splicing is part of the expression
program of a large number of genes in animals and
plants. It allows the selection of different combinations
of splice sites within a given pre-mRNA, generating
structurally and functionally distinct protein isoforms
(Breitbart et al. 1987; Manley and Tacke 1996; Ca´ceres
and Krainer 1997). Several protein factors involved in the
regulation of alternative splicing have been described,
including a family of RNA-binding proteins containing
arginine/serine-rich regions (SR proteins) (for reviews,
see Fu 1995; Chabot 1996; Valcarcel and Green 1996;
Ca´ceres and Krainer 1997). SR proteins are highly con-
served nuclear phosphoproteins that are members of a
protein family and share a serine phospho-epitope recog-
nized by the monoclonal antibody mAb104 (Roth et al.
1991). They consist at least of one RNA-binding domain
(RBD) [the typical RBD or RNA recognition motif (RRM)
domain of ~ 80 amino acids] (Birney et al. 1993), and pos-
sess several serine/arginine (SR) dipeptides near their
carboxy termini (Zahler et al. 1992). In general, SR pro-
teins are a defined subgroup of a large superfamily of
nuclear proteins with RS-rich domains of variable se-
quence and position (Fu 1995).
The human SF2/ASF splicing factor, a prototype SR
protein, is essential for the first cleavage step in pre-
mRNA splicing (Krainer et al. 1990b; Ge et al. 1991) and
can also determine in a concentration-dependent man-
ner which 58 splice site is selected in pre-mRNAs con-
taining alternative sites (Ge and Manley 1990; Krainer et
al. 1990a). The preferential usage of the proximal 58
splice site at higher concentrations of SF2/ASF is coun-
teracted by members of the hnRNP A/B family of pro-
teins (Mayeda and Krainer 1992; Mayeda et al. 1994),
suggesting that the relative abundance of these and pos-
sible other antagonistic splicing factors determines the
patterns of alternative splicing in vitro and in vivo (May-
eda and Krainer 1992; Ca´ceres et al. 1994; Yang et al.
1994; Wang and Manley 1995; Hanamura et al. 1998).
SF2/ASF and any other SR protein can complement
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splicing-deficient S100 extracts that essentially lack SR
proteins, but individual SR proteins sometimes display
distinct specificities and efficiencies in splicing different
pre-mRNAs (Krainer et al. 1990b; Ge et al. 1991; Fu and
Maniatis 1992; Kim et al. 1992; Mayeda et al. 1992; Fu
1993; Zahler et al. 1993; Screaton et al. 1995; Wang and
Manley 1995). Furthermore, an important activity of
SF2/ASF and other SR proteins is the interaction with
exonic enhancer sequences, which stimulate usage of an
adjacent weak splice site (Sun et al. 1993; Tian and Ma-
niatis 1993; Staknis and Reed 1994; Ramchatesingh et al.
1995; Tacke and Manley 1995; Lou et al. 1996). The
RNA-binding specificity of an SR protein is conferred by
the RRM region and adjacent sequences (Ca´ceres and
Krainer 1993; Zuo and Manley 1993; Tacke and Manley
1995; Allain and Howe 1997; Tacke et al. 1997); the vari-
ous RS domains are responsible primarily for protein–
protein interactions, which are modulated by the phos-
phorylation status of these regions (Wu and Maniatis
1993; Amrein et al. 1994; Kohtz et al. 1994; Zuo and
Maniatis 1996; Xiao and Manley 1997). In addition, it has
been demonstrated that RS domains modulate the RNA-
binding activity and subnuclear localization of SR pro-
teins (Li and Bingham 1991; Hedley et al. 1995; Ca´ceres
et al. 1997). Recently, SF2/ASF, SRp20, and 9G8 have
been shown to shuttle between the nucleus and the cy-
toplasm, and this property depends on the presence and
type of RS domain (Ca´ceres et al. 1998).
The studies described above led to the proposal that SR
proteins might function by bridging splice sites through
RNA–protein and protein–protein interactions, therefore
establishing early interactions for splice-site definition
and for the assembly of spliceosomes. These interactions
are stimulated by binding of SR proteins to nearby en-
hancer sequences and modulated by phosphorylation/
dephosphorylation of the RS regions.
There is limited information about the regulation of
SR protein expression in vivo. In the case of SF2/ASF and
SRp20, significant differences in mRNA and protein lev-
els have been observed in various cell types and tissues
(Jumaa et al. 1997; Hanamura et al. 1998). SC35 expres-
sion is also highly variable in cell lines (Fu and Maniatis
1992; Vellard et al. 1992) and some SR proteins are acti-
vated by mitogens (Diamond et al. 1993; Screaton et al.
1995). Interestingly, several alternatively spliced SR pro-
tein mRNAs have been described, which code for trun-
cated proteins of still unknown function (Ge et al. 1991;
Cavaloc et al. 1994; Screaton et al. 1995; Jumaa et al.
1997). Human SRp20 autoregulates its expression at the
level of splicing by binding to its own pre-mRNA,
thereby preventing overexpression of the active protein
(Jumaa and Nielsen 1997). It was found recently that the
amounts of alternatively spliced mRNAs coding for
SRp30b and SRp20 in Caenorhabditis elegans may be
regulated at least in part at the level mRNA stability
(Morrison et al. 1997).
Little is known about the mechanisms of intron exci-
sion in plant cells. It is generally assumed that the basic
mechanism of splicing in plants is similar to that of
yeast and mammals (Solymosy and Pollak 1993; Lu-
ehrsen et al. 1994; Filipowicz et al. 1995; Brown and
Simpson 1998). Nevertheless, animal introns are not pro-
cessed in any plant tissue so far examined (Barta et al.
1986; Van Santen and Spritz 1987; Wiebauer et al. 1988).
Apparently, the process of intron recognition differs in
these two kingdoms. One of the determining features of
introns in plants seems to be an U- or AU-rich character,
whereas the exons are more GC-rich (for review, see
Brown and Simpson 1998). As SR proteins play a critical
role in correct splice-site selection in mammals, it is of
interest to characterize the corresponding protein family
in plants. We screened for similar proteins in plants pre-
viously by using the mAb104 antibody or a specific
monoclonal antibody raised against human SF2/ASF,
and demonstrated that plants do possess SR proteins,
including SF2/ASF-like proteins (Lopato et al. 1996a).
However, the plant SR proteins are of different size and
are smaller than 55 kD. We further showed that plant SR
proteins are active in constitutive and alternative splic-
ing when assayed in heterologous HeLa cell extracts.
In an effort to isolate individual plant splicing factors,
we have characterized arginine/serine-rich proteins from
Arabidopsis belonging to two different families (Lopato
et al. 1996b; 1999). Both families show good homology in
the amino-terminal RRM with animal SR proteins, but
at their carboxy-terminal domains they are richer in ar-
ginine than in serine, have few SR dipeptides, and they
were therefore termed RS proteins. Nevertheless, these
proteins are recognized by the mAb104 antibody and can
complement SR protein-deficient HeLa S100 extracts ef-
ficiently .
As described in this manuscript, we have now isolated
and partially sequenced a plant protein immunoreactive
with a human SF2/ASF antibody. This information was
used to isolate a gene and a cDNA from Arabidopsis
with significant homology to human SF2/ASF, which we
termed atSRp30. Interestingly, this protein also has
~ 80% similarity to a SF2/ASF-like splicing factor from
Arabidopsis characterized previously (originally termed
SR1, but in accordance with our nomenclature we pro-
pose renaming this protein atSRp34/SR1) (Lazar et al.
1995). We show that in spite of their extensive sequence
homology atSRp30 and atSRp34/SR1 are differentially
expressed in distinct types of plant cells, thus indicating
their different functions. Both SR proteins are alterna-
tively spliced, with the ratios of the different isoforms
varying in different tissues and during development of
the plant. Overexpression of atSRp30 under the control
of a nonspecific promoter in transgenic Arabidopsis
plants leads to changes in alternative splicing of its own
pre-mRNA and of pre-mRNAs of several other genes,
showing that atSRp30 is a modulator of splicing.
Results
Isolation and sequencing of genomic and cDNA clones
of atSRp30
We initially identified plant SR proteins in magnesium
chloride pellets from protein extracts of carrot and to-
Lopato et al.
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bacco cell cultures and from Arabidopsis plants. The
proteins were detected with the monoclonal antibody
mAb104, specific for a shared phosphoepitope in all SR
proteins, and with a monoclonal antibody specific for the
human SF2/ASF splicing factor (Lopato et al. 1996a). A
protein of ~ 50 kD from the carrot SR preparation, which
was recognized by both antibodies, was isolated and par-
tially sequenced. Two peptides with significant homol-
ogy to human SF2/ASF and atSRp34/SR1 were found.
The first peptide comprised the RNP-2 submotif of the
first RRM, and the second peptide had high homology to
a sequence situated between RNP-2 and RNP-1 of the
second RRM (see Materials and Methods; Fig. 2, below).
Based on these sequences, degenerate primers were syn-
thesized and used for PCR on purified genomic DNA
from carrot, tobacco, and Arabidopsis. Sequencing of the
cloned PCR products revealed two very homologous se-
quences from Arabidopsis and tobacco. The Arabidopsis
fragment was 838 bp long and contained five introns.
The fragment borders of the Arabidopsis fragment are
marked with black arrows in Figure 1A. The protein se-
quence deduced from the PCR sequence had extensive
homology to both human SF2/ASF and atSRp34/SR1
(Fig. 2). The PCR product from Arabidopsis was used as
a probe to screen a l ZAPII genomic library of A.
thaliana. One genomic clone was found and designated
GatSRp30 (genomic clone of Arabidopsis thaliana ser-
ine/arginine-rich protein with deduced molecular mass
of ~ 30 kD). It was >4.5 kb long, had 1805 bp of promoter
region, but ended 12 bp upstream of the stop codon. A
Figure 1. Nucleotide and deduced pro-
tein sequences of atSRp30 and of atSRp34.
(A) Genomic sequence of atSRp30; pro-
moter and intron sequences are indicated
in lowercase, cDNA sequences in upper-
case, and the TATA box in bold italics.
The deduced protein sequence is shown
below the DNA in the one-letter code. The
bold sequence in the tenth intron is in-
cluded in alternatively spliced mRNAs,
and the underlined sequence is included
when both cryptic 38 and 58 splice sites are
used. The conserved RNP submotifs of
both RRMs are boxed. The open arrows
mark the ends of promoter sequences used
for expression studies. Solid horizontal ar-
rows indicate the ends of the PCR product
obtained with degenerate primers and
used as a probe for library screening. (fl )
The end of the GatSRp30 clone. The se-
quence data of the atSRp30 gene was sub-
mitted to the EMBL database (accession
no. AJ131214). (B) Schematic representa-
tion of GatSRp30, its mRNA isoforms,
and deduced proteins. Exons are shown as
boxes and introns as lines (bold lines: in-
trons included in the alternatively spliced
mRNAs). Exonic 58 and 38 untranslated re-
gions are shaded, and the coding regions
are black. (*) The new stop codon in the
alternatively spliced products. (C) Sche-
matic representation of GatSRp34, its
mRNA isoforms, and deduced proteins.
The drawings are as in B (accession no.
AF001035). (D) Partial genomic sequence
of atSRp34/SR1 starting from exon 10 up
to the stop codon. The bold sequence in
the long intron is included in alternatively
spliced mRNAs; the underlined sequence
is included when both cryptic 38 and 58
splice sites are used.
atSRp30, a splicing modulator from Arabidopsis
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corresponding cDNA was obtained from an expressed
sequence tag (EST) cDNA library of A. thaliana ecotype
Columbia and sequenced. The mRNA corresponding to
this cDNA was designated mRNA1 of atSRp30. Primers
derived from the 38 untranslated region of this cDNA
were used to obtain the missing sequences of the geno-
mic clone by PCR amplification on purified genomic
DNA. The DNA fragment contained an additional in-
tron and the rest was identical to the corresponding se-
quence of the cDNA1. The sequence of GatSRp30 and
the deduced protein sequence are shown in Figure 1A.
To facilitate comparison of features of atSRp30 and of
the closely related Arabidopsis atSRp34/SR1 protein
(Lazar et al. 1995), the genomic sequence of this protein
was determined using PCR. GatSRp34 has a very similar
gene structure to that of GatSRp30, except for an intron
present in the 58-untranslated region of the former. The
fragment of GatSRp34 comprising the part from exon 11 to
the stop codon is shown in Figure 1C, where the alterna-
tive splicing events involving intron 11 are also indicated.
Comparison of atSRp30 to other SR proteins
The deduced protein sequences of atSRp30 and atSRp34/
SR1 are very homologous (80.7% similarity and 67.1%
identity) to each other and both show very high similar-
ity (75.3 and 77.8%, respectively) and identity (58.1 and
59.4%, respectively) to human SF2/ASF (Fig. 2). As
atSRp30 and atSRp34/SR1 are less homologous to other
animal or plant SR proteins identified to date, both pro-
teins can be considered true orthologs of human SF2/
ASF. Within their amino-terminal portions, all three
proteins contain two RRMs with their conserved RNP-2
and RNP-1 submotifs, whereby the second RRM is atypi-
cal and contains the invariant SWQDLKD signature
characteristic of SF2/ASF-like SR proteins (Birney et al.
1993). However, unlike atSRp34/SR1 and SF2/ASF, the
RRMs of atSRp30 are not separated by a glycine-rich
‘hinge’ region but rather by a serine-rich sequence. The
RS domain of atSRp30 is shorter than the one of atSRp34
because of an extension at the 38 end of atSRp34, which
includes a previously described positively charged pro-
line/serine/lysine-rich (PSK) domain of unknown func-
tion (Lazar et al. 1995). If this unique 38 extension is not
taken into account, atSRp34/SR1 is slightly more ho-
mologous to human SF2/ASF, mainly because of their
common G-rich hinge region. Taken together, these
analyses suggest that in contrast to mammals, for which
only one SF2/ASF protein has been described to date,
two SF2/ASF homologs exist in Arabidopsis.
RNA distribution and alternative splicing forms
of atSRp30 and atSRp34/SR1
RNA blots of poly(A)+ mRNA from various tissues of
wild-type Arabidopsis plants were probed with radioac-
tive labeled atSRp30 or atSRp34/SR1 cDNAs and re-
vealed at least two mRNA species in each case (Fig. 3A).
The level of expression of each gene varied considerably
in different tissues but in both cases was highest in flow-
ers, followed by roots (Fig. 3A). In addition, the ratio of
the two discernible mRNAs, mRNA3 and mRNA1, was
different for each gene in the various organs. For
atSRp30, mRNA3 seemed to be more abundant in
leaves, stems, and flowers, whereas mRNA1 was pre-
dominant in roots. In contrast, the ratio of the two main
mRNAs of atSRp34/SR1 was ~ 1:1 in leaves and stems,
whereas in roots and flowers mRNA1 predominated.
Reprobing of the RNA blot with the long tenth intron of
atSRp30 showed that mRNA3 retained sequences of this
intron, indicating that alternative splicing involves this
region of atSRp30 pre-mRNA.
The full sequences of the various mRNA isoforms
were obtained by RT–PCR cloning from total RNA using
primers from the 58 and 38 ends of the genes (see Mate-
rials and Methods). mRNA1 corresponded to the cDNA
Figure 2. Alignment of Arabidopsis atSRp30, atSRp34/SR1, and human SF2/ASF protein sequences. (Solid area) Positions at which
a single residue occurs in at least two of the sequences. (Shaded areas) Conservative substitutions such as RK, IVL, ED, FY, ST. The
positions of the conserved RNP-1 and RNP-2 submotifs and the glycine-rich region are indicated.
Lopato et al.
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sequence of atSRp30, whereas mRNA3 retained part of
the tenth intron, because of usage of an alternative 38
splice site (Fig. 1A,B). The mRNA2 isoform with both
alternative 38 and 58 splice sites within intron 10 (Fig.
1A,B) was not visible in Northerns of wild-type plants
(see Fig. 3A) and was only detected by RT–PCR by in-
creasing the number of cycles (data not shown).
The same approach was used to sequence the mRNA
isoforms of atSRp34/SR1 (Fig. 1C). The longest mRNA
species, which is also the most abundant in wild-type
plants, was named mRNA5 and retained most of intron
11 (which is in the position corresponding to intron 10 of
atSRp30) except for an internal intron of ~ 80 nucleo-
tides. Two other minor alternative mRNAs could be de-
tected during early plant development, but only by RT–
PCR (data not shown). mRNA4 uses an additional alter-
native 38 splice site; mRNA2 uses alternative 58 and 38
splice sites (Fig. 1C,D); and mRNA3, which is the main
alternatively spliced mRNA in plants when atSRp30 is
overexpressed from the 35SCaMV promoter (Fig. 5, be-
low), uses one alternative 58 splice site.
The above alternatively spliced mRNAs of atSRp30
and atSRp34/SR1 all had an in-frame stop codon near the
58 end of the retained intronic sequences. The hypotheti-
cal shorter proteins, designated atSRp30s and atSRp34s,
lack the carboxy-terminal part of the RS domain and
instead have other sequences that are shown in bold in
Figure 1A for atSRp30s and in Figure 1C for atSRp34s.
To obtain information about changes in the transcrip-
tional and alternative splicing patterns of atSRp30 dur-
ing plant development, total RNA was isolated from
whole plants of different ages and used for RNA blot
hybridization and RT–PCR analysis (Fig. 3B,C). Primers
derived from exons adjacent to the 10th intron were used
for RT–PCR. The results from both methods were in
good agreement and showed that the expression of
mRNA1 is highest in younger plants and starts to de-
cline around day 12, whereas the expression of mRNA3
is extremely low in young seedlings, peaks between days
9–14, and declines slowly afterward. Although we do not
know how the ratio of these two transcripts is regulated,
these regulatory events might determine the quantity of
genuine atSRp30 protein in individual cells.
Antibody detection of Arabidopsis SR proteins
Polyclonal antibodies were raised in chickens against pu-
rified recombinant atSRp30 and atSRp34/SR1 and used
to identify antigens in different ammonium sulfate frac-
tions of Arabidopsis extracts. The extracts were fraction-
ated by sequential precipitation with ammonium sulfate
and magnesium chloride, to enrich for SR proteins (Roth
et al. 1990). The anti-p30 and anti-p34 antibodies recog-
nized proteins in the 60%–90% ammonium sulfate cut.
The immunoreactive proteins in the dialyzed 60%–90%
cut precipitated quantitatively in the presence of 20 mM
magnesium chloride. No crossreaction of plant proteins
with the pre-immune immunoglobulin fraction was
found (data not shown).
The magnesium precipitate was immunoblotted and
probed with four different antibodies. With anti-p30, six
protein bands were detected as three doublets, with the
43- to 46-kD doublet showing the highest intensity. The
two other doublets migrated with apparent molecular
masses of 38–40 and 31–34 kD (Fig. 4A, lane 2). The
immunostaining pattern with the monoclonal antibody
mAb104 (Fig. 4A, lane1), which is specific for a serine
phosphoepitope common to SR proteins (Roth et al.
1990) was very similar, although the smallest band was
more pronounced than with anti-p30 (lane 2). This could
be indicative of an additional SR protein of ~ 30 kD, or it
may reflect the presence of multiple or stronger phos-
phoepitopes within p30. We did not detect high molecu-
lar mass proteins with the mAb104 antibody, although
(Lazar et al. 1995), have reported immunoreactive pro-
teins up to 120 kD.
The anti-p34 antibodies recognize mainly three pro-
teins of ~ 46–47, 40, and 34 kD. As the same antibody
shows minimal cross-reaction with recombinant
atSRp30 (data not shown), these bands probably repre-
sent atSRp34/SR1-related proteins and correlate well
with published overexpression data in which the protein
Figure 3. Expression of atSRp30 and atSRp34/
SR1 in wild-type Arabidopsis thaliana. (A) Ex-
pression in different plant tissues. Northern blot
analysis of poly(A)+ RNA from leaves (L), stems
(S), roots (R), and flowers (F) is shown. One mi-
crogram of RNA was loaded per lane and the
blots were either probed with a probe corre-
sponding to the tenth intron of GatSRp30, or
with the cDNAs of atSRp30 or atSRp34/SR1.
(B,C) Developmental expression of atSRp30. To-
tal RNA was isolated from whole plants on dif-
ferent days during development starting from
the day of germination. The RNA was either
used for Northern blot analysis with 10 µg/lane
of total RNA and the membrane probed with
atSRp30 cDNA (B), or for analysis of the RT–
PCR products on a 1.2% agarose gel (C). The two
primers for the PCR reaction were located in the
exons adjacent to the tenth intron.
atSRp30, a splicing modulator from Arabidopsis
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was immunodetected with a size of 47–48 kD (Lazar et
al. 1995). The 40-kD protein comigrates with an alterna-
tively spliced isoform of atSRp34/SR1 (see below),
whereas the nature of the 34-kD polypeptide remains to
be determined. Interestingly, the immunoblot with anti-
p34 is very similar to that obtained with a monoclonal
antibody specific for human SF2/ASF (Fig. 4A, cf. lanes 3
and 4). Therefore, anti-hSF2, which recognizes a discon-
tinuous epitope within RRM1 of hSF2/ASF but does not
recognize other human SR proteins (Hanamura et al.
1998) cross-reacts with the same set of Arabidopsis pro-
teins as anti-p34, supporting the notion that hSF2/ASF
resembles atSRp34/SR1 in this region more closely than
it does atSRp30.
The fact that atSRp30 and atSRp34/SR1 are present in
the SR protein preparation and comigrate with specific
bands in the mAb104 immunoblot suggests that both
proteins are phosphorylated. To test this suggestion, we
treated the SR protein preparation with increasing con-
centrations of alkaline phosphatase and for different
times (Fig. 4B,C). Compared to the untreated controls
(lanes 1,2), these treatments resulted in an increase in
the mobility of all immunostained bands. Under these
conditions, anti-p30 recognized predominantly three
proteins (27, 31, and 38 kD), whereas anti-p34 recognized
two proteins (31 and 38 kD). As expected, all these pro-
teins were no longer stained with mAb104, except for
the 38-kD band, which probably represents a partially
dephosphorylated intermediate resistant to further de-
phosphorylation (data not shown). Interestingly, dephos-
phorylation led to the appearance of new bands of higher
apparent molecular mass, consistent with our observa-
tion that unphosphorylated recombinant atSRp30 and
atSRp34/SR1 are very insoluble and have a strong ten-
dency to aggregate.
Transcriptional activity of SR protein promoters
in Arabidopsis
It is striking that in contrast to mammals, Arabidopsis
possesses two SF2/ASF-like proteins. As revealed by the
Northern blot analysis, the genes of both proteins are
transcribed in all plant organs. It was therefore of inter-
est to investigate if both genes are generally transcribed
in all tissues or specifically in different tissues, or to
which extent they have overlapping activities. To this
end, the promoters of GatSRp30 and GatSRp34, includ-
ing the 58-untranslated regions up to the start codon,
were fused to the coding region of a reporter b-glucuron-
idase gene and transferred into A. thaliana plants by
Agrobacterium tumefaciens-mediated root transforma-
tion. b-Glucouronidase (GUS) activity was never ob-
served in any tested nontransgenic Arabidopsis tissues,
as well as in transgenic plants harboring a promoterless
GUS gene. Control plants containing a 35S cauliflower
mosaic virus (CaMV) promoter–GUS fusion were easily
stained, demonstrating that substrate accessibility was
not limiting GUS activity. To exclude an influence of
the transgene position on promoter activity, the analyses
were carried out with several independent transgenic
lines.
Using detailed histochemical analyses, we found that
both genes had distinct but also overlapping patterns of
transcriptional activities. Flowers in the postanthesis
stage (Fig. 5A,E) showed essentially the same staining
patterns for both genes, with the most pronounced ex-
pression in the pollen grains and weak staining of sepals
and style. Additionally, weak activity was observed in
the abscission zone of the flower in atSRp30–GUS trans-
genic plants (Fig. 5A). The leaves of atSRp30–GUS plants
showed strongest staining in vascular bundles and in the
support cells of each trichome (Fig. 5B), whereas the
atSRp34–GUS fusion was weakly active only in second-
ary veins and in the cells around them, but activity was
never observed in trichomes or support cells (Fig. 5F).
The differences in the GUS-staining patterns of these
genes were especially evident during the different stages
of lateral root development. Both atSRp30 and atSRp34–
GUS fusions were active at the very first stages of lateral
root initiation, when pericycle cells are stimulated, de-
differentiate, and proliferate. Then, at the later stages,
when redifferentiation occurs to form the lateral root
Figure 4. Immunodetection of phos-
phorylated and dephosphorylated SR
proteins from cell cultures of Arabidop-
sis. (A) Immunodetection of proteins in
SR protein preparations (lanes 1–4).
(Lane 1) Monoclonal antibody mAb104,
which is specific for a common phos-
phoepitope of SR proteins; (lane 2) poly-
clonal antibody raised against recombi-
nant atSRp30; (lane 3) polyclonal anti-
body raised against recombinant
atSRp34/SR1; (lane 4) monoclonal anti-
body specific for human SF2/ASF. Pro-
tein markers are indicated at the left.
(B,C) Dephosphorylation of SR proteins
with alkaline phosphatase. (Lanes 1,2) SR proteins incubated at 37°C without enzyme for 0 and 24 hr, respectively; (lanes 3,4) SR
proteins incubated with 0.2 and 1.0 U/µl of enzyme for 3 hr; (lanes 5,6) SR proteins incubated with 1.0 and 2.0 U/µl of enzyme for 24
hr. Proteins were probed either with anti-p30 (B) or anti-p34 (C).
Lopato et al.
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meristem, atSRp30–GUS was expressed in the basal en-
larged cells of the forming lateral root (Fig. 5C), whereas
atSRp34–GUS expression was characteristic of the acti-
vated root meristem (Fig. 5G). The staining patterns dur-
ing early seedling development provided additional evi-
dence for the distinct transcriptional activities of
atSRp30 and atSRp34/SR1. Each of the genes was ex-
pressed in specific regions along the apical–basal axis of
the seedling. In atSRp30–GUS seedlings, expression was
restricted to the cotyledons (Fig. 5D), whereas in
atSRp34–GUS seedlings, expression was observed in hy-
pocotyl and in root (Fig. 5H), suggesting that these genes
can be transcriptionally active in regions with different
patterns of cell division. This suggestion was confirmed
by differential expression of atSRp30 and atSRp34/SR1
during lateral root formation, as well as in trichome sup-
port cells.
Overexpression of atSRp30 in transgenic plants
In Drosophila, ectopic overexpression of SRp55/B52 re-
sulted in various developmental abnormalities, although
the identity of affected transcripts remains unknown
(Kraus and Lis 1994). It was therefore of interest to study
the effect of overexpression of atSRp30 on plant devel-
opment and on the alternative splicing patterns of indi-
vidual plant transcripts. The constructs used contained
either a complete gene (pG30) or a cDNA (pC30) encod-
ing atSRp30 under the control of the strong constitutive
promoter of the 35S RNA from CaMV. The 35S CaMV
promoter is strong and constitutive in all plant tissues
studied, which was confirmed in control experiments
using GUS as a reporter gene. To control for the condi-
tions of the regeneration and transformation procedure
in the RNA analysis of transformants, negative controls
were either transformed with a 35SRNA promoter–GUS
control (pBI121) or were transformants with the same
construct, but which for unknown reasons did not show
overexpression.
Both fusion constructs, pG30 and pC30, were used for
Agrobacterium-mediated transformation of Arabidopsis
roots. Forty independent transgenic lines were regener-
ated for each construct; eight of the lines transformed
with pG30 and twelve transformed with pC30 were used
in further work. Some of these transgenic lines were
used for RNA blot and RT–PCR analyses as shown in
Figure 6, A and B. Surprisingly, all pG30 transformants
(Fig. 6A,B, lines 1–4) expressed mainly mRNA3, which
Figure 5. Transcriptional analysis of atSRp30 (A–D) and atSRp34/SR1 (E–H) promoter–GUS fusions in transgenic Arabidopsis. GUS
staining of (A,E) flowers at the postanthesis stage; (B,F) staining patterns in the leaves; (C,G) primary and developing lateral roots; (D,H)
seedlings (2 days after germination).
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possesses an alternative 38 splice site within the long
intron (Fig. 1B); nevertheless, mRNA1 was still more
abundant in these plants than in the control plant (Fig.
6A, lane 10), as judged by the RNA blot analysis (four
times more product was loaded in lane 10 in Fig. 6B).
Although mRNA1 levels in both types of transformants
are quite different (Fig. 6A), the RT–PCR shows similar
yields (Fig. 6B) because a high number of cycles was em-
ployed to detect all alternatively spliced products. As
expected, all transformants containing pC30 overex-
pressed only mRNA1 (Fig. 6A, lanes 5–9). In both types
of transformants, overexpressed mRNAs were >100-fold
more abundant than in wild-type plants. Interestingly,
when pC30 transformants were analyzed by RT–PCR,
only mRNA2, which uses cryptic 38 and 58 splice sites in
intron 10 (Figs. 6B and 1B), was present, whereas a small
amount of mRNA3 was visible in wild-type plants. This
result shows that an excess of atSRp30 changes 58 splice-
site selection of the endogenous atSRp30 pre-mRNA.
In light of the above results, it was of interest to mea-
sure overexpression of atSRp30 at the protein level. To-
tal soluble protein extracts of transgenic plants were ana-
lyzed by Western blotting using anti-p30 for immunode-
tection (Fig. 6C) and compared to a control plant (lane 8,
a transformed plant with no overexpression of atSRp30)
and to an SR protein preparation from an Arabidopsis
suspension culture (lane 1). The SR protein preparation
had the characteristic pattern for anti-p30 (cf. Figs. 6C,
lane 1, and 4A, lane 2), whereas no specific proteins were
immunostained in the total protein extract of the control
plant (Fig. 6C, lane 8), because of the low abundance of
atSRp30 in plants. In contrast, a specific protein band
was visible in the pC30 transformants (lanes 3–7), comi-
grating with a protein band in the SR protein preparation
(lane 1). In contrast, in the pG30 transformant (lane 2),
only a faint protein band was detected. These results
correlate well with the RNA expression pattern of
mRNA1 in both types of transformants (Fig. 6A). It is
interesting that overexpression of atSRp30 yielded an
immunostained protein of 38 kD and not a band comi-
grating with the more abundant 43- to 46-kD doublet
seen in the SR protein preparation (Fig. 6C, lane 1). One
likely explanation is that overexpressed atSRp30 is only
partially phosphorylated, which may be related to our
observation that even exhaustive dephosphorylation re-
sults in a 38-kD atSRp30 protein that retains the
mAb104 phosphoepitope (Fig. 4B, lanes 3–6). However,
no shorter protein product (atSRp30s) of the highly abun-
dant mRNA3 in pG30 transformants could be detected
with any antibody used (see also Fig. 6C, lane 2).
Phenotypic changes in plants overexpressing atSRp30
Overexpression of atSRp30 resulted in strong pheno-
types with pleiotropic changes both in morphology and
development of the transgenic plants. No significant dif-
ferences were observed between plants transformed with
pG30 and pC30 constructs, although the levels of
atSRp30 protein were different (Fig. 6C, cf. lane 2 and
lanes 3–7). The observations were reproducible in T2 and
subsequent generations of independent transgenic lines,
and cosegregated with antibiotic resistance. In trans-
genic plants, the transition from vegetative to flowering
stage was delayed greatly under short day conditions.
The time from germination to the formation of the first
mature silique was 65–78 days in overexpressing plants,
compared to 42–47 days in control plants grown under
the same conditions. In addition, adult plants showed
reduced apical dominance, resulting in a ‘bushy’ pheno-
type with an increased number of secondary inflores-
cences and a shortened primary inflorescence (Fig. 7C).
Growing of the transgenic plants under long-day condi-
tions resulted in partial reversion to a normal phenotype.
Figure 6. Overexpression of atSRp30 in transgenic Arabidop-
sis plants. The cDNA and the genomic sequences of atSRp30
were cloned under the control of the strong 35S CaMV promoter
(constructs pC30 and pG30, respectively) and used to transform
Arabidopsis plants. (A) Northern blot analysis of total RNA
isolated from independent transgenic lines probed with
atSRp30 cDNA. (Lanes 1–4) Plants transformed with the pG30
construct; (lanes 5–9) plants transformed with pC30; (lane 10)
control plant transformed with pBI121 (35S CaMV–GUS con-
struct). mRNA isoforms are indicated. (B) RT–PCR analysis of
the same transgenic lines. The primers used are indicated with
arrows in the diagram of GatSRp30. (Lane 10) Four times more
material was loaded in this control lane. (C) Immunodetection
of atSRp30 in total protein extracts of overexpressing transgenic
plants. (Lane 1) SR protein preparation from Arabidopsis cell
culture (wild type); (lane 2) line transformed with pG30; (lanes
3–7) lines transformed with pC30; (lane 8) pC30 transgenic line
that does not overexpress mRNA1. Antibody raised against
atSRp30 (anti-p30) was used for immunodetection.
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But despite of the partial recovery of apical dominance,
the transition to flowering and the time to senescence
remained delayed. Under long-day conditions, the major-
ity of plants from overexpressing lines started to flower
between 35 and 39 days after germination, whereas con-
trol plants flowered between days 25 and 28. The initial
inflorescences were very short and did not exceed 0.5–1
cm when the first flower opened. The size of flowers in
transgenic plants was ~ 30% larger than in control plants
(4 and 3 mm, respectively). Transgenic plants also had
larger rosette leaves (Fig. 7A, cf. to wild type in B) with
trichomes having predominantly four to five 5 branches,
compared to wild-type leaves, which had mainly three-
branched trichomes. In strong overexpressing lines, the
primary inflorescence produced numerous secondary
branches with a vegetative rosette-like appearance.
These branches developed from 7–15 vegetative-like
leaves and finally formed inflorescences. Under long-day
conditions, the rosette leaf numbers determined at the
time of flowering were somewhat lower in transgenic
lines compared to the wild type (at average 12 and 16
leaves, respectively). Independent transgenic lines over-
expressing atSRp30 displayed the described characteris-
tics to various extents, with the main impact on the time
for transition from the vegetative to the reproductive
phase.
Overexpressed atSRp30 modulates alternative splicing
in vivo
The influence of overexpression of atSRp30 on its own
alternative splicing pattern and the high homology of
atSRp30 to human alternative splicing factor SF2/ASF
suggested that this protein could be a modulator of plant
splicing. This assumption cannot be tested in vitro, as no
plant splicing extracts are available. We therefore used
total RNA preparations from pG30 transformants (lower
level of atSRp30 overexpression) and pC30 transfor-
mants (higher level of atSRp30 overexpression) for RT–
PCR analysis of several plant introns that are known to
be processed alternatively under wild-type conditions.
Among several genes tested, such as FCA (Macknight
et al. 1997), rubisco activase (Werneke et al. 1989), aga-
mous (Yanofsky et al. 1990), and LSD1 (Dietrich et al.
1997), no changes in the splicing patterns were observed
in plants overexpressing atSRp30. However, pre-mRNA
splicing of three plant genes was found to be affected by
overexpression, as described below.
The splicing factor atRSp31 belongs to a novel family
of plant RS proteins and possesses an alternatively
spliced second intron (792 nucleotides) (Lopato et al.
1996b). In the wild-type plant, either a cryptic 38 splice
site or both alternative 38and 58 splice sites were used in
this intron (Fig. 8A), whereas the latter form prevailed in
control lines (lane 1) and pG30 transformed lines (lanes
(2–5). In contrast, pC30 lines (lanes 6–10) expressed
mainly the alternative 38 splice site form, although its
abundance was variable (in lanes 6 and 7 this form is
only visible in the original photograph). These tran-
scripts are probably subject to nonsense-mediated decay
and potentially code for the same truncated protein.
Another well-described alternative splicing event oc-
curs in the case of the U1–70K gene of Arabidopsis, in
which transcripts retaining intron 6 are more abundant
in most tissues (except roots) than the correctly spliced
transcript (Golovkin and Reddy 1996). The RT–PCR re-
sults from control plants (Fig. 8B, lanes 1,9,10) confirm
this observation. However, in both atSRp30 transfor-
mants, either the lower expressing pG30 lines (lanes 2
and 3) or the higher expressing pC30 lines (lanes 4–8),
most of the transcripts were spliced correctly and only a
low level of intron retention was observed. This regula-
tory event could potentially influence the level of active
protein.
The most interesting case of alternative splicing
modulation was found in the case of the long intron (in-
tron 11) of GatSRp34, which is a close homolog of
GatSRp30 (Fig. 9). In wild-type plants (Fig. 9, lane 1), part
of this intron is alternatively spliced to generate
mRNA5. However, in pG30 transformants (lanes 2–5),
mRNA 3 was the main alternatively spliced form,
whereas the level of mRNA1 appeared unchanged. Sur-
prisingly, when atSRp30 was highly overexpressed, the
alternatively spliced mRNA3 became the main tran-
script, whereas the amount of mRNA1 was considerably
decreased. Assuming that shorter PCR products are prob-
ably overrepresented, the reduction of mRNA1 may be
even more drastic. This assumption was confirmed by
immunoblot analysis of total protein extracts: atSRp34/
Figure 7. Phenotypic changes in plants
overexpressing atSRp30. (A) Plant overex-
pressing atSRp30; (B) wild-type plant; (C)
plant overexpressing atSRp30 grown under
short day conditions displays no apical
dominance, resulting in a bushy pheno-
type.
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SR1 was detected in control plants (Fig. 9B, lane 3) and in
a pG30 transformant (lane 5), but not in a pC30 trans-
formant (lane 4). However, a smaller specific protein
band (atSRp34s, 38 kD) became visible in this case, in-
dicating that the protein product of mRNA3 predomi-
nates in this transformant. These results clearly show
that overexpression of atSRp30 strongly influences gene
expression of its close homolog, atSRp34/SR1.
Discussion
atSRp30 is a member of the SR protein family
In addition to their characteristic domains, which in-
clude one or two RRMs and a carboxy-terminal RS do-
main with multiple SR dipeptides, SR proteins possess
phosphoepitope(s) recognized by mAb104 and they are
insoluble in the presence of millimolar concentrations of
magnesium salts. The antibody to atSRp30 recognized a
complex pattern of bands in the Mg precipitate, whereas
in total protein fractions no specific band could be de-
tected. The failure to detect atSRp30 in crude lysates
reflects the low abundance of the protein and/or the lim-
ited sensitivity of the antibody. However, when atSRp30
was overexpressed, the antibody detected a specific pro-
tein with an apparent mobility of 40 kD. In contrast,
atSRp34/SR could be detected by anti-p34 in total pro-
tein fractions. Our immunoblot data confirm that
atSRp30 is a true SR protein, as it is present in SR protein
preparations and shows corresponding immunostained
bands with mAb104. However, as complete dephospory-
lation could not be achieved, we do not know how many
of these proteins represent modified forms of atSRp30 or
closely related proteins.
Is the expression of atSRp30 autoregulated?
When atSRp30 pre-mRNA was overexpressed, mRNA3,
which is generated from use of an alternative 38 splice
site in the tenth intron, was the main transcript de-
tected, whereas the level of mRNA1 was enhanced only
moderately (Fig. 6). There are several possible explana-
tions for this phenomenon. First, there may be a limiting
splicing factor that is titrated out because of overexpres-
sion of the atSRp30 gene. Such a factor would have to be
specific for the tenth intron, as all the other introns in
atSRp30 are spliced properly. Second, mRNA3 and
mRNA1 may be synthesized for the most part in differ-
ent cells, via cell-type-specific alternative splicing. As
the constitutive 35S CaMV promoter used in the over-
expression experiments is active in most tissues, the
large amount of mRNA3 may reflect inappropriate ex-
pression in cell types in which a factor required for cor-
rect processing of the tenth intron is absent. To clarify
this issue, experiments aimed at determining the cells in
which the alternative splicing event takes place will be
necessary.
The fact that the ratio of mRNA 3 to mRNA 1 is con-
stant in all transformants overexpressing GatSRp30 (Fig.
6A) is consistent with a potential autoregulatory mecha-
nism involving atSRp30. Overproduced atSRp30 protein
may stimulate the alternative splicing event, thus down-
regulating its own expression, as has been shown to be
Figure 8. Regulation of the alternative splicing pattern of
atRSp31 and U1–70K in plants overexpressing atSRp30. The
relevant alternative splicing events are shown in the diagrams
at the top. RT–PCR was carried out using primers (marked with
arrows) derived from the adjacent exons. (A) Changes in splicing
in the second intron of GatRSp31. (Lane 1) Control line trans-
formed with pBI121 (35SCaMV–GUS construct), (lanes 2–5)
lines transformed with the pG30 construct; (lanes 6–10) lines
transformed with pC30. (B) More correctly spliced mRNA en-
coding U1–70K protein is produced upon overexpression of
atSRp30. (Lane 1) control plant transformed with pBI121
(35SCaMV–GUS construct); (lanes 2,3) lines transformed with
the pG30 construct; (lanes 4–8) plants transformed with pC30;
(lane 9) control pC30 transgenic plant that does not overexpress
mRNA1; (lane 10) 19-day-old wild-type plant.
Figure 9. Changes in the expression pattern of atSRp34/SR1 in
plants overexpressing atSRp30. (A) Preferential usage of an al-
ternative 58 splice site in the eleventh intron of atSRp34/SR1.
The gene, the relevant alternative splicing events, and the de-
duced proteins are depicted above the gel showing the RT–PCR
products obtained with primers from the adjacent exons. (Lane
1) Control, untransformed wild-type plant; (lanes 2–5) lines
transformed with the pG30 construct; (lanes 6–11) plants trans-
formed with pC30; (lane 11) control pC30 transgenic plant that
does not overexpress mRNA1. (B) Immunodetection of atSRp34
and atSRp34s in total protein extracts from transgenic plants.
(Lanes 1,2) SR protein preparations isolated from Arabidopsis
plants and cell culture, respectively; (lane 3) control plant trans-
formed with pC30 that does not overexpress mRNA1; (lane 4)
line transformed with pC30; (lane 5) line transformed with the
pG30 construct. Anti-p34 antibodies were used for immunode-
tection.
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the case for several animal splicing factors, such as Sxl
(Bell et al. 1991), tra (Mattox and Baker 1991), and SWAP
(Zachar et al. 1987) from Drosophila, as well as mouse
SRp20 (Jumaa and Nielsen 1997). In agreement with this
model, we could not detect a protein product from
mRNA3 (atSRp30s). We obtained evidence for an influ-
ence of atSRp30 on alternative splicing of transcripts
from the endogenous gene in plants overexpressing the
atSRp30 cDNA (Fig 6B, lanes 5–9), resulting in preferen-
tial use of an alternative 58 splice site. Overexpression of
atSRp30 might have a different effect on the large
amount of exogenous pre-mRNA present in cells where
this protein is not expressed normally, resulting in pref-
erential use of an alternative 38 splice site (Fig. 6A,B,
lanes 1–4). Unfortunately, this hypothesis cannot be
tested in vitro because no plant splicing extracts are
available. Future experiments should address whether
atSRp30 can indeed autoregulate its own production.
atSRp30 overexpression influences splice-site choice
in several plant pre-mRNAs and induces changes
in plant development
Many in vivo and in vitro experiments have shown that
human SF2/ASF is involved in the selection of 58 splice
sites by binding cooperatively to this site (Zuo and Man-
ley 1994) and to U1 snRNP (Kohtz et al. 1994; Jamison et
al. 1995; Zahler and Roth 1995). Furthermore, like other
SR proteins, SF2/ASF influences splice-site selection in
part by binding to enhancer sequences that are present
frequently in intronic or exonic regions. Upon binding to
these elements, the protein activates splicing by recruit-
ing the splicing machinery to an adjacent splice site
through protein–protein interactions (Wu and Maniatis
1993; Amrein et al. 1994; Zuo and Manley 1994). Arabi-
dopsis atSRp30 was a good candidate for being a splicing
modulator, given its similarity to human SF2/ASF and
its peculiar expression pattern. The ability to stably
overexpress atSRp30 in whole plants that remained vi-
able allowed us to determine, for the first time, the ef-
fects of increased SR protein levels on alternative splic-
ing of specific endogenous transcripts. Some but not all
endogenous transcripts tested were affected. In the case
of atSRp30 pre-mRNA itself, and of atSRp34/SR1 pre-
mRNA, intronic alternative 58 splice sites were acti-
vated, whereas in atRSp31 and U1 70K pre-mRNAs, the
usage of the normal splice sites was generally enhanced
but variable. We have no explanation for this variability
in individual transformants (see Fig. 8), as the atSRp30
protein levels in several pC30 transformants were simi-
lar (Fig. 6C). The most pronounced effect of atSRp30
overexpression was on the splicing pattern of the close
homolog atSRp34/SR1, in which preferential use of the
alternative 58 splice site gave rise mostly to a truncated
mRNA isoform, atSRp34s, and virtually no atSRp34/
SR1 protein. Although we have no information to date
concerning the activity of the smaller atSRp34s, these
results suggest that normal expression of atSRp30 pro-
tein in the same cells that transcribe atSRp34/SR1 is
important for the synthesis of authentic atSRp34/SR1
protein. This regulatory loop might explain the different
expression patterns of both factors in root tissue and
young seedlings. It remains to be determined whether
there is a reciprocal effect of atSRp34/SR1 overexpres-
sion on alternative splicing of atSRp30 pre-mRNA.
Plants overexpressing atSRp30 constitutively and
ubiquitously showed interesting changes in morphology,
as well as in several aspects of development. Although
some of the details will have to be investigated more
thoroughly, many of the differences can be explained by
changes in phase transitions and in the definition of cell
fates. In this work, we have demonstrated that atSRp30
can change the expression of other genes drastically by
influencing their splicing patterns. As the expression
pattern of atSRp30 is normally very tissue specific, some
of the observed effects of overexpression might simply be
caused by its expression in inappropriate tissues, where
it influences the expression of genes that are not the
natural targets of this splicing factor. In addition, the
observed decrease in the expression of the splicing factor
atSRp34 upon overexpressing atSRp30 may in turn affect
the expression of other genes, leading to the observed
phenotypic changes. On the other hand, the changes in
trichome development resulting in additional branching
may reflect overexpression of atSRp30 in the supporting
cell of the trichomes, which is a normal site of atSRp30
expression. Therefore, atSRp30 may be a determinant of
trichome development. Finding the natural targets of
regulation by atSRp30 remains a critical goal to explain
the observed changes in phenotype, as well as to promote
our understanding of developmental pathways in plants.
Two SF2/ASF-like splicing factors in Arabidopsis
Immunoblot analysis with mAb104 suggested previ-
ously that the complexity of the SR protein family is
higher in animals than in plants (Lopato et al. 1996a), as
several higher molecular mass proteins have been iden-
tified in SR preparations from mammals but not from
those in plants. The existence of two SF2/ASF-like fac-
tors in Arabidopsis may compensate for the absence of
orthologs of other members of the SR protein family.
The similar gene structure of atSRp30 and atSRp34/SR1
is indicative of an ancestral gene duplication event. In-
terestingly, the penultimate long intron is conserved in
both genes and is involved in alternative splicing events.
Judging from Northern blot analysis of RNAs from dif-
ferent plant organs, the ratio of the various SR protein
mRNAs is quite variable and is probably reflected in the
abundance of the resulting proteins. In both genes, the
alternative splicing event results in predicted proteins
with a truncated RS region and a few new additional
carboxy-terminal amino acids. Whereas a shorter protein
of atSRp34/SR1 could be detected clearly in plants over-
expressing atSRp30, we never observed atSRp30s in
these plants, although the corresponding alternatively
spliced mRNA is abundant. Expression of atSRp30s
cDNA in Escherichia coli yielded stable protein (data not
shown). Therefore, either mRNA3 is not translated effi-
ciently, or it is degraded through a premature nonsense
atSRp30, a splicing modulator from Arabidopsis
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codon-mediated decay pathway, or atSRp30s is preferen-
tially recognized by one of the plant protein-degradation
systems.
Comparative analysis of atSRp30 with all known plant
and animal SR proteins revealed that it is a paralog of
atSRp34/SR1 and that both Arabidopsis proteins are
closest to human SF2/ASF. The main structural differ-
ence is that atSRp30 lacks a G-rich region between the
two RRMs, which may influence the flexibility and per-
haps the specificity of the RNA-binding region. The no-
tion that the two proteins might have distinct activities
is strengthened by the observation that in many cases
their expression patterns are quite different, as shown in
Figure 5. In general, atSRp30 expression is more confined
to specialized cell types and tissues, like trichomes,
cotyledons, or lateral root primordia, suggesting a special
role for this protein in the initiation of organ formation,
whereas atSRp34/SR1 is more strongly expressed in
meristematic tissue. Furthermore, our sequence and im-
munological data indicate that atSRp34/SR1 is more
similar to hSF2/ASF than is atSRp30. Taken together,
these data suggest that atSRp34/SR1 is a more general
splicing factor, similar to hSF2/ASF, whereas atSRp30
might have more specialized functions, perhaps acting as
a regulatory splicing factor that modulates alternative
splicing and gene expression in specific cell types.
Materials and methods
Purification of SR proteins and protein sequencing
The SR protein purification was described previously (Lopato et
al. 1996a). The proteins were separated by SDS-PAGE. After
Coomassie G staining, the protein bands were excised and sub-
jected to in-gel digestion with Lys-C endopeptidase. The result-
ing peptides were separated by HPLC and sequenced by auto-
mated Edman degradation as described previously (Wang et al.
1996).
Isolation and sequencing of genomic DNA and cDNA
of atSRp30 and atSRp34/SR1
Total DNA of carrot, tobacco, and Arabidopsis was isolated by
the cetyltrimethylammonium bromide (CTAB) method (Mur-
ray and Thompson 1980). The most conserved part of the se-
quenced peptide YVGNLPGDI was used to design two degen-
erate forward primers. Two reverse degenerate primers were
derived from the peptide sequence SWQDLKDHM, which was
also part of a sequenced peptide. All four combinations of de-
generate primers were used in PCR reactions with genomic
DNA from different plants as a template. PCR products were
subcloned and sequenced. The PCR product from Arabidopsis
was used as a probe for screening a genomic lZAPII library of A.
thaliana var. Columbia (Stratagene). One positive clone,
GatSRp30, was found, mapped, subcloned, and sequenced
(EMBL accession no. AJ131214). A partial cDNA sequence was
found by a BLAST search through the EST databases with the
accession no. R65514, 4018 Arabidopsis thaliana cDNA clone
17J1T7, and was kindly provided by the Arabidopsis Biological
Resource Center at Ohio State University. Sequence homology
was analyzed using Genetics Computer Group (GCG, Univer-
sity of Madison, Madison, WI) sequence analysis software pack-
age version 7.1-UNIX. Sequencing of the cDNA and the geno-
mic clones was done using an A.L.F. DNA Sequencer and Auto
Read Sequencing kit (Pharmacia). To obtain a cDNA clone of
atSRp34/SR1, the EST clone with the accession no. ACT76795,
11573 atcDNA clone 151I9T7, was sequenced. The genomic
sequences for atSRp34/SR1 (accession no. AF001035) were iso-
lated by PCR and sequenced.
Analysis of alternatively spliced isoforms
RNA blot analyses were done as described (Lopato et al. 1996b).
cDNAs encoding alternatively spliced isoforms were obtained
by RT–PCR using total RNA preparations from A. thaliana
plants at different stages of development and primers derived
from the 38 untranslated region (for reverse transcription).
(1) 58-AAATGAGCTCAAATGTATATGTATGGAAAAACC-38
(atSRp30) and (2) 58-AATGAGCTCGAAACGATATCTTCAA-
AAAAAAAC-38 (atSRp34/SR1) (the underlined nucleotides corre-
spond to restriction sites) and from the beginning of the
58 untranslated region and the end of coding region (for PCR);
(3) 58-AAACTGGATCCAGAACAATCTAACGCTTTCTCG-38
(atSRp30) and (4) 58-ATATAGGATCCTCAACCAGAUAUCA-
CAGGTG-38 (atSRp30); (5) 58-AAATATCTAGAGATCTCAAA-
TCGACGACC-38 (atSRp34/SR1) and (6) 58-ATATAGGATC-
CCATTTTACCTCGATGGAC-38 (atSRp34/SR1). All PCR prod-
ucts were sequenced. Alternative splicing of the long introns was
studied using primers derived from adjacent exons; (7) 58-AAT-
GAGCTCTGTGTCACCTGCTAGATCC-38 (atSRp30) and (8)
58-ATATAGGATCCAGATATCACAGGTGAAAC-38 (atSRp30);
(9) 58-ATAGGATCCAGGAGCAGAAGTCCCAAGGCAAAG-38
(atSRp34/SR1) and (10) 58-AAAGTCGACAGAAGGTAGAGGA-
GATCTTGATC-38 (atSRp34/SR1). The fragments were analyzed
on a 1.2 % agarose gel.
Constructs for promoter analysis and overexpression
Aproximately 1 kb of promoter sequences of atSRp30 and
atSRp34/SR1 plus their complete 58 untranslated regions (in-
cluding the first intron in the case of atSRp34/SR1) were ob-
tained by PCR from genomic clone GatSRp30 and genomic
DNA of A. thaliana, respectively, as a template, using primers
(11) 58-AAACTAAGCTTGGTATCTTCTTCCCTGCAAG-38
(atSRp30); (12) 58-AAACCTAGGCGGCTACTCAGCTGATA-
CCTCAGAGCAG-38 (atSRp30); (13) 58-AAACTAAGCTTAA-
ATATTGAACCGGCCTCGGTTC-38 (atSRp34/SR1); (14) 58-
AAACTGGATCCTCTTCCTGTTGGTCGTCGACGATTTG-38
(atSRp34/SR1); and (15) 58-AAACTGGATCCTCTTCCTT-
TATCAAATCC-38 (atSRp34/SR1) containing HindIII and
BamHI restriction sites. These fragments were digested with
HindIII and BamHI and fused to the GUS reporter gene (Jeffer-
son 1987) in pBI101 (Clontech).
The cDNA and genomic sequences of atSRp30 were amplified
from cDNA and genomic DNA from A. thaliana using primers
3 and 1, containing BamHI and SacI restriction sites, respec-
tively. The DNA fragments were sequenced and inserted into
the BamHI–SacI restriction sites of the pBI121 (Clontech) vector
(with the GUS gene deleted) under the control of the 35S CaMV
promoter, giving rise to constructs named pC30 and pG30, re-
spectively.
Cultivation of plants and suspension cultures and plant
transformation procedure
Conditions for maintaining carrot and tobacco BY2 suspension
cultures were as described earlier (Lopato et al. 1996a). The
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suspension culture of A. thaliana ecotype Columbia was a gift
from Czaba Koncz (Max-Planck-Institut fu¨r Zu¨chtungsforsch-
ung, Ko¨ln, Germany) and was maintained as described in
(Lopato et al. 1999). A. thaliana ecotype Columbia was used in
all transfer experiments. Seeds were surface-sterilized by a 30-
min imbibition with water, followed by a 1-min incubation in
70% ethanol, 10 min in 10% bleach and five rinses with sterile
water. Sterilized seeds were grown in MS medium (Murashige
and Skoog 1962), supplemented with 1% sucrose. Plants were
usually maintained in 16-hr light/8-hr dark cycle at 23°C, ex-
cept as otherwise indicated. The cell culture was grown in me-
dium containing Murashige and Skoog salts, 2× Gamborg’s vi-
tamins (Gamborg et al. 1968), 1 mg/liter 2,4-dichlorophenoxy-
acetic acid (2,4-D), and 3% (wt/vol) sucrose. Cell cultures were
incubated in 50 ml of medium in 250-ml conical flasks on a
rotary shaker at 110 rpm at 23°C in dim light. Cell suspensions
were subcultured every 7 days and were diluted threefold with
fresh medium at each subculture.
All constructs were introduced into Agrobacterium tumefa-
ciens LBA4404 (Hoekema et al. 1983) using a triparental mating
procedure with the helper plasmid pRK2013 (Ditta et al. 1980).
Root explants of A. thaliana were transformed using the
method described by (Valvekens et al. 1988) with one modifi-
cation: Root explants were taken from 15-day-old seedlings
grown on vertically placed agar plates (Huang and Ma 1992).
Seeds of transgenic plants were germinated in the presence of 50
µg/ml of kanamycin.
Histochemical assay of GUS expression
Histochemical assays of GUS expression were carried out with
5-bromo-4-chloro-3-indolyl glucuronide (X-Gluc, Duchefa) as a
substrate and were performed on intact seedlings or excised
organs of mature plants grown in vivo as described by Jefferson
(1987). The samples were treated with 70% ethanol for 2–6 hr to
remove chlorophyll from tissues where necessary.
Purification of SR proteins from Arabidopsis
and immunoblotting
SR proteins were purified from 3-week-old Arabidopsis plants
or 5-day-old suspension cultures using a two-step salt precipi-
tation method as described (Lopato et al. 1996a). Total protein
extracts were prepared with the buffer for SR protein isolation
(Zahler et al. 1992). Proteins from the magnesium precipitate
and total protein extracts were separated on a 12.5% SDS gel.
Protocols for immunoblotting and detection were described ear-
lier (Lopato et al. 1999). Protein dephosphorylation was carried
out with alkaline phosphatase from calf intestine (Biolabs).
Expression of atSRp30 and atSR34/SR1 in bacteria
The coding region of atSRp30 cDNA was amplified by PCR
using the primers 58-ATATACCATGGGTAGCCGATGGA-
ATCGTAC-38 and 4 (listed above).
The coding region of atSRp34/SR1 cDNA was amplified by
PCR using the primers 58-ATATACCATGGGCAGTCGTTC-
GAG-38 and 6 (above). The primers contain NcoI and BamHI
restriction sites. To obtain the NcoI restriction site, the fourth
nucleotide of the coding region in both cases was changed to G.
Thus expressed atSRp30 and atSRp34/SR1 have Ser2-Arg and
Ser2-Gly substitutions, respectively. The fragments were
cloned into the bacterial expression vector pET-3d (Novagen)
and transformed into the E. coli strain BL21(DE3)pLysS (Nova-
gen).
Single colonies were grown in 100 ml of LB medium to a
density of 0.4–0.5 OD550, transferred to 900 ml of fresh pre-
warmed medium and incubated for 1 hr. The cultures were
induced with 0.4 mM IPTG and were grown for a further 5 hr.
The bacterial pellet was washed twice in 500 ml of ice-cold
washing buffer (100 mM NaCl, 10 mM Tris-HCl at pH 7.5) and
used for inclusion body isolation: 2 grams of bacterial pellet was
resuspended in 18 ml of ice-cold buffer A (10 mM Tris-HCl at pH
7.9, 100 mM KCl, 2 mM DTT, 35% sucrose). A total of 4.5 ml of
ice-cold buffer B (333 mM Tris-HCl at pH 8.0, 100 mM EDTA at
pH 8.0, 40 mg of lysozyme) was added and incubated on ice for
at least 10 min. Lysis buffer (22.5 ml, 1 M LiCl, 20 mM EDTA,
0.5% NP-40) was added and the solution was sonicated for a
total of 2 min at full power (15-sec bursts with cooling periods
of 1 min in between). Following centrifugation for 10 min (Sor-
vall, SS34, 13000 rpm), the pellet was washed twice in 25 ml of
buffer C (10 mM Tris-HCl at pH 8.0, 0.1 mM EDTA, 0.5 M LiCl,
0.05% NP-40, 1 mM DTT), and then twice with the same buffer
lacking LiCl. The isolated inclusion bodies contained >95%
pure protein and were used for polyclonal antibody preparation
(Lopato et al. 1999).
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